Spots Global Cancer Trial Database for Early Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Early Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether)

Official Title: Early Integration of Supportive Care Into Standard Oncology Care for Metastatic Uveal Melanoma Patients

Study ID: NCT04728113

Conditions

Uveal Melanoma

Interventions

Supportive care visit with questionnaires

Oncological standard visit

Study Description

Brief Summary: The study main objective is to assess whether the early introduction of supportive care demonstrates a benefit on patients' psychological care needs at 6 months (M6), versus oncological standard of care in patients with metastatic UM. Supportive care in patients with metastatic Uveal Melanoma (UM)

Detailed Description: Before the start of the study, medical oncologists and supportive care physicians from both the sites will attend Communication Skills Training (CST) workshops provided by an expert team in the field. The training sessions will focus on practicing the required communication skills needed in consultations. The randomization will assign patients, with a 1:2 ratio, to "Introduction of supportive care when medically needed" (Arm A: Control Group) or "Initial concomitant management by the oncologist and the supportive care team" (Arm B: Early Together Group). Selected and validated questionnaires will be filled at baseline, 6 and 12 months by the patients before the consultation, in the 2 groups.